MRI 导引神经外科消融市场规模、份额、成长分析（按产品、适应症、最终用途和地区）- 产业预测，2025 年至 2032 年

MRI 导引的神经外科消融市场规模预计在 2023 年达到 5.9 亿美元，并从 2024 年的 6.3543 亿美元增长到 2032 年的 11.5025 亿美元，预计在预测期内（2025-2032 年）的复合年增长率为 7.7%。

由于神经系统疾病和脑肿瘤的增加以及向微创手术技术的转变，神经外科市场正在大幅扩张。这些先进的手术使用专门的设备来最大限度地减少组织损伤和手术风险，由于恢復时间更快、切口更少而受到患者的青睐。伦敦大学学院开发的一种新型癌症治疗方法利用 MRI 精确摧毁肿瘤而不损害健康组织，这种创新技术使治疗更加有效。此外，高解析度 MRI 技术的进步使得手术过程中可以进行即时视觉化，从而提高安全性和患者的治疗效果。美国癌症协会预测，2023 年将有近 24,810 例脑和神经系统癌症新病例，对这些微创治疗的需求可能会持续成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究

MRI 导引神经外科消融市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• MRI 导引雷射消熔系统
• MRI 导引射频消融系统
• MRI 导引聚焦超音波系统
• 配件

MRI 导引神经外科消融市场规模（按适应症和复合年增长率）（2025-2032）

• 市场概况
• 瘤
• 癫痫
• 疼痛管理
• 血管畸形

MRI 导引神经外科消融市场规模（按最终用途和复合年增长率划分）（2025-2032 年）

• 市场概况
• 医院
• 诊所
• 门诊手术中心

MRI 导引神经外科消融市场规模和复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Monteris Medical（美国）
• InSightec Ltd.（以色列）
• Profound Medical Corp.（加拿大）
• 美敦力公司 (爱尔兰)
• 波士顿科学公司（美国）
• AngioDynamics Inc.（美国）
• ClearPoint Neuro, Inc.（美国）
• Elekta AB（瑞典）
• Accuray Incorporated（美国）
• Brainlab AG（德国）
• 瓦里安医疗系统（美国）
• 雅培实验室（美国）
• 西门子医疗股份公司（德国）
• 飞利浦医疗保健（荷兰）
• GE医疗（美国）

结论和建议

MRI-Guided Neurosurgical Ablation Market size was valued at USD 590.0 million in 2023 and is poised to grow from USD 635.43 million in 2024 to USD 1150.25 million by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The market for neurosurgery is expanding significantly, driven by an increase in nervous system disorders and brain tumors, alongside a shift toward minimally invasive surgical techniques. These advanced procedures, which minimize tissue injury and surgical risks through specialized equipment, are preferred by patients due to their expedited recovery times and fewer incisions. Innovations, such as a new cancer treatment developed at UCL that utilizes MRI for precise tumor destruction, are further enhancing treatment efficacy without harming healthy tissue. Additionally, advancements in high-resolution MRI technology enable real-time visualization during surgeries, improving safety and patient outcomes. As the American Cancer Society projects nearly 24,810 new cases of brain and nervous system cancers in 2023, the demand for these less invasive treatments will continue to rise.

Top-down and bottom-up approaches were used to estimate and validate the size of the Mri-Guided Neurosurgical Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Mri-Guided Neurosurgical Ablation Market Segments Analysis

Global MRI-Guided Neurosurgical Ablation Market is segmented by Product, Indication, End-Use and region. Based on Product, the market is segmented into MRI Guided Laser Ablation Systems, MRI Guided RF Ablation Systems, MRI Guided Focused Ultrasound Systems and Accessories. Based on Indication, the market is segmented into Tumors, Epilepsy, Pain Management and Vascular Malformations. Based on End-Use, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Mri-Guided Neurosurgical Ablation Market

The MRI-Guided Neurosurgical Ablation market is primarily fueled by the rising incidence of neurological disorders. These conditions, which significantly affect the nervous system, often lead to severe or even life-threatening consequences for patients. As such, there is an escalating need for effective treatment options. Innovative therapies, particularly MRI-guided neurosurgical ablation, have gained traction due to their precision and effectiveness in treating complex neurological issues. This growing acceptance of advanced, minimally invasive techniques represents a pivotal shift in the management of neurological diseases, further driving the market demand for MRI-guided neurosurgical ablation solutions.

Restraints in the Mri-Guided Neurosurgical Ablation Market

The MRI-guided neurosurgical ablation market faces significant restraints primarily due to insurance and reimbursement challenges. Although these innovative procedures provide promising treatment options for patients with neurological disorders, inconsistencies in insurance coverage and reimbursement policies can create substantial financial barriers. Many insurance providers may not offer comprehensive coverage for MRI-guided neurosurgical ablation, resulting in patients having to pay a considerable portion of the costs themselves, which may deter them from pursuing these treatments. Furthermore, the absence of standardized reimbursement protocols across different regions and insurance plans exacerbates these financial challenges, leading to varied access for patients and potentially hindering the widespread adoption of this advanced technology. Addressing these issues is essential to facilitate fair access to MRI-guided neurosurgical ablation and encourage its integration into standard healthcare practices.

Market Trends of the Mri-Guided Neurosurgical Ablation Market

The MRI-guided neurosurgical ablation market is witnessing a significant shift towards patient-centric care, which is revolutionizing treatment paradigms by prioritizing individual patient needs and preferences. This trend underscores the importance of tailoring procedures to match specific patient conditions, enhancing the effectiveness of minimally invasive treatments. By fostering collaborative decision-making, patients become active participants in their healthcare journey, leading to improved satisfaction and outcomes. As this patient-centered model gains momentum, it aligns with the broader movement towards personalized and responsive healthcare services in neurosurgery, thereby positioning MRI-guided ablation as a cornerstone of modern, individualized patient care solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global MRI-Guided Neurosurgical Ablation Market Size by Product & CAGR (2025-2032)

• Market Overview
• MRI Guided Laser Ablation Systems
• MRI Guided RF Ablation Systems
• MRI Guided Focused Ultrasound Systems
• Accessories

Global MRI-Guided Neurosurgical Ablation Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Tumors
• Epilepsy
• Pain Management
• Vascular Malformations

Global MRI-Guided Neurosurgical Ablation Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Ambulatory Surgical Centers

Global MRI-Guided Neurosurgical Ablation Market Size & CAGR (2025-2032)

• North America (Product, Indication, End-Use)
  • US
  • Canada
• Europe (Product, Indication, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Indication, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Indication, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Indication, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Monteris Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSightec Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Profound Medical Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ClearPoint Neuro, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainlab AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations